MetaCap

Emmis Acquisition (EMIS) vs Vogenx (VOGX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Vogenx is the larger company by market cap ($176.3 million vs $163.4 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EMIS+1.32%VOGX-8.69%
+171%+77%-17%
Aug 12, 20261 yearNov 20, 2026
EMIS+1.32%VOGX-19.69%
+137%+55%-27%
Aug 10, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EMIS versus VOGX key metrics
MetricEMISVOGX
Share price$10.36$11.87
Market cap$163.36M$176.33M
1-day change+0.15%-7.30%
YTD return+4.07%—
1-year return+4.39%—
EPS (TTM)—$-0.89
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$10.38$38.41
52-week low$9.92$11.51
Distance from 52-week high-0.24%-69.10%
Analyst consensus—strong_buy
Avg. price target upside—+363.35%
Average volume16.19K128.78K
Shares outstanding11.94M14.86M
Employees—4
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Emmis Acquisition

EMIS stock →

Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Health Care · Biotechnology: Pharmaceutical Preparations

About Vogenx

VOGX stock →

Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

EMIS vs VOGX FAQ

Which is bigger, Emmis Acquisition or Vogenx?

Vogenx (VOGX) is larger, with a market capitalization of $176.33M compared with $163.36M for Emmis Acquisition (EMIS).

Are Emmis Acquisition and Vogenx in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons